1-3 of 3
Alexandria T. Phan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Old Drug New Use—Amoxapine and Its Metabolites as Potent Bacterial β-Glucuronidase Inhibitors for Alleviating Cancer Drug Toxicity

Available to Purchase
Ren Kong, Timothy Liu, Xiaoping Zhu, Syed Ahmad, Alfred L. Williams, Alexandria T. Phan, Hong Zhao, John E. Scott, Li-An Yeh, Stephen T.C. Wong
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (13): 3521–3530.
https://doi.org/10.1158/1078-0432.CCR-14-0395
Published: 30 June 2014
View articletitled, Old Drug New Use—Amoxapine and Its Metabolites as Potent Bacterial β-Glucuronidase Inhibitors for Alleviating Cancer Drug Toxicity
Open the PDF for Old Drug New Use—Amoxapine and Its Metabolites as Potent Bacterial β-Glucuronidase Inhibitors for Alleviating Cancer Drug Toxicity in another window
Includes: Supplementary data
Journal Articles

New Strategies for Advanced Neuroendocrine Tumors in the Era of Targeted Therapy

Available to Purchase
Mei Dong, Alexandria T. Phan, James C. Yao
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (7): 1830–1836.
https://doi.org/10.1158/1078-0432.CCR-11-2105
Published: 01 April 2012
View articletitled, New Strategies for Advanced Neuroendocrine Tumors in the Era of Targeted Therapy
Open the PDF for New Strategies for Advanced Neuroendocrine Tumors in the Era of Targeted Therapy in another window
Journal Articles

PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors

Available to Purchase
Funda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, Kim-Anh Do, Takafumi Sangai, Farrell Adkins, Ana Maria Gonzalez-Angulo, Asif Rashid, Katherine Crosby, Mei Dong, Alexandria T. Phan, Robert A. Wolff, Sanjay Gupta, Gordon B. Mills, James Yao
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (6): 1777–1789.
https://doi.org/10.1158/1078-0432.CCR-11-2123
Published: 14 March 2012
View articletitled, PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors
Open the PDF for PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors in another window
Includes: Supplementary data